Expert Evaluation of Clinical AI Tools on Real Point-of-Care Clinical Queries

📅 2026-06-27
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the gap in clinical AI evaluation, which often relies on hypothetical questions and lacks validation by domain experts in real-world settings. The authors introduce Real-POCQi, a dataset of 620 authentic frontline clinical queries, and conduct a large-scale blinded assessment involving 149 specialist physicians who evaluated responses from three general-purpose large language models and the specialized tool OpenEvidence across five dimensions—including accuracy and clinical utility. This work presents the first large-scale expert-aligned, query-grounded blind evaluation, demonstrating that the specialized tool significantly outperforms general models across all dimensions (win-rate advantages of 25–39 percentage points, p<0.001), with results robust to multiple sensitivity analyses. The study also reveals systematic discrepancies between automated LLM scoring and expert judgments. The Real-POCQi benchmark and analysis pipeline are publicly released to establish a new paradigm for clinical AI evaluation.
📝 Abstract
Physicians now pose millions of clinical questions to AI tools each week, yet these tools are evaluated largely on hypothetical or exam-style questions, not those actually asked in practice. We report a blinded evaluation built on 620 Real-world Point-Of-Care Queries (Real-POCQi) submitted to the OpenEvidence (OE) platform by physicians spanning 30 specialties, as well as 187 questions from HealthBench. 149 practicing physicians across 36 states made head-to-head comparisons between answers from three frontier general-purpose models (Claude Opus 4.8, Gemini 3.1 Pro, and GPT-5.5) and a specialized clinical tool (OE), with graders matched to each question's specialty. When comparing answers along five dimensions relevant to clinical decision support -- accuracy, clinical utility, source quality, verifiability, & completeness -- physicians scored the specialized tool highest on all axes; in the primary analysis on Real-POCQi, win differences (margins between win and loss rates) ranged from 25 to 39 percentage points (p<0.001). Results remained consistent in sensitivity analyses stratifying by citation display, answer length, OE-user status, and Real-POCQi versus HealthBench. In parallel, LLM judges were found to systematically differ from expert judges, though both generally agreed on the best model. These findings underscore two conclusions: (i) AI tool evaluations should reflect real-world query distributions and use expert judges that mirror the specialization defining modern medicine and (ii) the consistent advantage of the specialized tool over general-purpose models does not necessarily mean that the latter cannot serve similar purposes, but that targeted engineering and customization can yield meaningful gains in performance for its users. We release Real-POCQi as a public benchmark, as well as the prespecified statistical analysis for reproducing results of this study.
Problem

Research questions and friction points this paper is trying to address.

clinical AI evaluation
real-world queries
point-of-care
expert assessment
AI benchmarking
Innovation

Methods, ideas, or system contributions that make the work stand out.

real-world clinical queries
expert evaluation
specialized clinical AI
benchmark dataset
blinded head-to-head comparison
🔎 Similar Papers
No similar papers found.
Jean Feng
Jean Feng
Department of Epidemiology and Biostatistics, University of California, San Francisco
machine learningstatisticsbiostatistics
V
Vishal Patel
Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women’s Hospital, Boston, Massachusetts, USA.
P
Patrick Heagerty
Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Yifan Mai
Yifan Mai
Research Engineer, Stanford CRFM
Machine Learning
Venkatesh Sivaraman
Venkatesh Sivaraman
Carnegie Mellon University
human-computer interactionvisualizationAIinterpretability
Patrick Vossler
Patrick Vossler
University of California, San Francisco
StatisticsCausal InferenceMachine LearningHigh-dimensional statisticsfeature selection
J
Jialin Ouyang
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
A
Anupam B. Jena
Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA.; National Bureau of Economic Research, Cambridge, Massachusetts, USA.